AI Science Tracker
EN

Learned mitochondrial expression patterns associate with kidney cancer survival

Dalian Medical University · 25 Sep 2023 · medicine

Discovery

Learned mitochondrial expression patterns associate with kidney cancer survival

Source check: Source checked. Not independent scientific confirmation.

Finding: Consensus clustering and Boruta selection separated mitochondrial-expression patterns in TCGA clear-cell renal cancer data, with different recorded overall survival. Iterative LASSO and survival forests also produced exploratory prognostic models fitted to these data. This is a retrospective association; optimized survival cutoffs and model selection make performance optimistic, and predicted drug sensitivity does not establish treatment response or a therapeutic mechanism.

Technology: Consensus clustering; Boruta; iterative LASSO; random survival forest

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Unsupervised clustering and forest-based feature selection learn mitochondrial-expression patterns that can be compared with recorded survival.
Test and result
Outcome associations of unsupervised expression groups and exploratory supervised prognostic fitting using recorded TCGA survival data.
Limitation / still unknown
Independent prognostic validation, causal mitochondrial mechanisms and clinical treatment utility remain unestablished; no held-out cohort is described for the reported model performance.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC10657316/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 21 Nov 2026. Review scope: Primary relevant model Methods, Results and limitations; exact primary identity and current primary PubMed correction/retraction relationships checked..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.